IGC Announces Results of its 2021 Annual Stockholders Meeting
October 15 2021 - 4:00PM
Business Wire
India Globalization Capital, Inc. (NYSE AMERICAN: IGC) announces
that during its Annual Meeting of Shareholders scheduled for and
convened on October 15, 2021, voting on all matters as disclosed on
the Definitive Proxy on Form 14A filed with the SEC on September
15, 2021, were passed. Only stockholders of record on the record
date of September 10, 2021, were entitled to and were being
requested to vote.
At the Annual Meeting, the following proposals were approved:
(i) the proposal to elect Mr. Richard Prins to the Company’s board
of directors to serve as a Class B director until the 2024 annual
meeting of Stockholders; (ii) the proposal to ratify Manohar
Chowdhry & Associates (“MCA”) as the Company’s independent
registered public accounting firm for the 2022 fiscal year; (iii)
the grant of 3,500,000 shares of common stock to be granted from
time to time to the Company’s current and new employees, advisors,
directors, and consultants by the board of directors, pursuant to
certain metrics including performance, vesting, and incentive as
set by the board of directors and or the CEO; and (iv) the proposal
to adjourn or postpone of the Annual Meeting to a later date or
dates, if necessary, to permit further solicitation and vote of
proxies.
About IGC
India Globalization Capital, Inc. (IGC) engages in the
development of cannabinoid-based therapies for indications such as
Alzheimer's disease and pain. It operates in two lines of business,
Infrastructure and Life Sciences and is headquartered in Potomac,
MD. www.igcinc.us, www.igcpharma.com, Twitter @IGCIR.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211015005595/en/
Claudia Grimaldi Email: info@igcinc.us Phone: 301-983-0998
IGC Pharma (AMEX:IGC)
Historical Stock Chart
From Aug 2024 to Sep 2024
IGC Pharma (AMEX:IGC)
Historical Stock Chart
From Sep 2023 to Sep 2024